Akre Focus Fund Retail Class (AKREX)
Fund Assets | 11.79B |
Expense Ratio | 1.33% |
Min. Investment | $2,000 |
Turnover | n/a |
Dividend (ttm) | 3.27 |
Dividend Yield | 4.98% |
Dividend Growth | 60.09% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 6, 2024 |
Previous Close | 65.68 |
YTD Return | 1.74% |
1-Year Return | 15.54% |
5-Year Return | 84.36% |
52-Week Low | 57.67 |
52-Week High | 71.98 |
Beta (5Y) | 1.12 |
Holdings | 17 |
Inception Date | Aug 31, 2009 |
About AKREX
The investment seeks long-term capital appreciation. The fund invests primarily in securities of companies listed on U.S. stock exchanges. Investments consist primarily of common stocks of companies of any size market capitalization. It may also invest in preferred stocks, warrants, options, and other equity-like instruments, such as partnership interests, limited liability company interests, business trust shares and rights, REITs, and other securities that are convertible into equity securities. The fund is non-diversified.
Performance
AKREX had a total return of 15.54% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.07%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
83.71% of assetsName | Symbol | Weight |
---|---|---|
Constellation Software Inc/Canada | CSU | 11.99% |
Mastercard Incorporated | MA | 11.28% |
KKR & Co. Inc. | KKR | 11.25% |
Moody's Corporation | MCO | 9.46% |
Visa Inc. | V | 8.76% |
Brookfield Corporation | BN | 8.35% |
O'Reilly Automotive, Inc. | ORLY | 6.68% |
Roper Technologies, Inc. | ROP | 6.50% |
CoStar Group, Inc. | CSGP | 5.03% |
The Oncology Institute, Inc. | TOI | 4.42% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 6, 2024 | $3.27259 | Dec 6, 2024 |
Dec 8, 2023 | $2.04421 | Dec 8, 2023 |
Dec 9, 2022 | $3.12043 | Dec 9, 2022 |
Dec 10, 2021 | $2.34014 | Dec 10, 2021 |
Dec 13, 2019 | $1.33069 | Dec 13, 2019 |
Dec 14, 2018 | $0.18811 | Dec 14, 2018 |